Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 25359988

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2014 Dec 18
First author
Hoelzer D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hoelzer D
      type
      Author
    2. name
      Walewski J
      type
      Author
    3. name
      Döhner H
      type
      Author
    4. name
      Viardot A
      type
      Author
    5. name
      Hiddemann W
      type
      Author
    6. name
      Spiekermann K
      type
      Author
    7. name
      Serve H
      type
      Author
    8. name
      Dührsen U
      type
      Author
    9. name
      Hüttmann A
      type
      Author
    10. name
      Thiel E
      type
      Author
    11. name
      Dengler J
      type
      Author
    12. name
      Kneba M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hoelzer D
      type
      Author
    2. name
      Walewski J
      type
      Author
    3. name
      Döhner H
      type
      Author
    4. name
      Viardot A
      type
      Author
    5. name
      Hiddemann W
      type
      Author
    6. name
      Spiekermann K
      type
      Author
    7. name
      Serve H
      type
      Author
    8. name
      Dührsen U
      type
      Author
    9. name
      Hüttmann A
      type
      Author
    10. name
      Thiel E
      type
      Author
    11. name
      Dengler J
      type
      Author
    12. name
      Kneba M
      type
      Author
    bibliography ids
    1. nci-bib-c860dd53ae3e4955fa37dd68
    book metadata
    content sha256
    6a34079c20de20685e2fadd9b308633b1141ee6c84399ac1b1373ce7a22ade0f
    document type
    citation
    dois
    1. 10.1182/blood-2014-03-563627
    electronic publication date
    display
    2014 Oct 30
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:25359988
    immutable id
    pubmed:25359988@6a34079c20de20685e2fadd9b308633b1141ee6c84399ac1b1373ce7a22ade0f
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    26
    name
    Blood
    nlm unique id
    7603509
    pages
    3870-9
    volume
    124
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      25359988
      provenance
      batch id
      863b068fe5a07222af6a
      provider
      NCBI PubMed ESummary
      record sha256
      cae0006d6ae0e597df094623af23f54b3f64217938a22ef320293840b10152c8
      response sha256
      80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
      retrieved at
      2026-09-09T23:47:07.648963+00:00
      publication date
      display
      2014 Dec 18
      precision
      day
      year
      2014
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/25359988/
      title
      Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice